Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

Merck’s Bavencio joins first-line kidney cancer face-off

PD-L1 and TKI combination could challenge standard of care

- PMLiVE

How pharma should navigate Artificial Intelligence (AI)

Developing an AI strategy that cuts through the hype

- PMLiVE

Encouraging data for GenSight’s blinding retinal disease gene therapy

Better results after April's setback

- PMLiVE

Lonely planet: why there is dwindling value in pharma travelling alone

To develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward

- PMLiVE

AZ and Clovis PARP inhibitors show their mettle at ESMO

Lynparza and Rubraca both on track to extend cancer patient reach

- PMLiVE

Dynavax is ‘deal-ready’ after solid ESMO data; analyst

Contrasting results for two novel immunotherapies

- PMLiVE

AZ and Medicines Catapult collaborate on innovative sound tech in drug discovery

Collaborates with Medicines Discovery Catapult on AMI-MS

Artificial intelligence in healthcare

What are the benefits for pharma?

- PMLiVE

Shire’s angioedema drug Takhzyro recommended in Europe

Analysts expect the drug to make around $1.8bn in peak sales

- PMLiVE

UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen

Big biopharma investment good news for gene sequencing company

Osteoporosis

Cuttsy+Cuttsy launch their latest patient e-book

On the eve of ‘World Osteoporosis Day’ (worldosteoporosisday.org), Cuttsy+Cuttsy are proud to launch their latest e-book ‘Osteoporosis…in plain English’.

Cuttsy + Cuttsy

- PMLiVE

McCann Health London launch Urban Eye Test

Initiative aims to encourage the public to check their vision

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links